Selenoprotein W engages in overactive osteoclast differentiation in multiple myeloma

Hyunsoo Kim,Jiin Oh,Min Kyoung Kim,Kyung Hee Lee,Daewon Jeong
DOI: https://doi.org/10.1007/s11033-024-09517-2
IF: 2.7422
2024-04-30
Molecular Biology Reports
Abstract:Patients with multiple myeloma exhibit malignant osteolytic bone disease due to excessive osteoclast formation and function. We recently identified that osteoclastogenic stimulator selenoprotein W (SELENOW) is upregulated via ERK signaling and downregulated via p38 signaling during receptor activator of nuclear factor (NF)-κΒ ligand (RANKL)-induced osteoclast differentiation. In the intrinsic physiological process, RANKL-induced downregulation of SELENOW maintains proper osteoclast differentiation; in contrast, forced overexpression of SELENOW leads to overactive osteoclast formation and function.
biochemistry & molecular biology
What problem does this paper attempt to address?